netFormulary NHS
North East and North Cumbria
ICS Formulary
 Search
 Recent Updates - Updated items

All Formulary Amendments

  Records 1 to 23 of 23


Details
UPD sitematrix Changed from 0 to
10/10/2023 13:16:42
(DavidS )
UPD FurtherInformation Changed from
  • Approved for treating severe eosinophilic asthma in adults in line with NICE and NHS England Commissioning Policy.

 

to
10/10/2023 13:16:42
(DavidS )
UPD Benralizumab (Fasenra®) addition of formulation info
10/10/2023 13:16:42
(DavidS )
UPD sitematrix Changed from 0 to
10/10/2023 13:14:28
(DavidS )
UPD FurtherInformation Changed from
  • Approved for treating severe eosinophilic asthma in adults in line with NICE and NHS England Commissioning Policy.



 

to
10/10/2023 13:14:28
(DavidS )
UPD Benralizumab (Fasenra®) updated formatting
10/10/2023 13:14:28
(DavidS )
UPD sitematrix Changed from 0 to
10/10/2023 13:14:10
(DavidS )
UPD FurtherInformation Changed from

  • Approved for treating severe eosinophilic asthma in adults in line with NICE and NHS England Commissioning Policy.


 

to
10/10/2023 13:14:10
(DavidS )
UPD Benralizumab (Fasenra®) updated formatting
10/10/2023 13:14:10
(DavidS )
DUP Item ID 5471 : Moved from 03.04.02 to 03.04.02
10/10/2023 13:12:38
(DavidS )
DUP Item ID 5471 : Moved from 03.04.02 to 03.04.02
05/05/2023 10:36:58
(ebeavers )
UPD sitematrix Changed from 0 to
17/12/2021 11:10:41
(LoweryM )
UPD FurtherInformation Changed from

 

    • Approved for treating severe eosinophilic asthma in adults in line with NICE

 

to
17/12/2021 11:10:41
(LoweryM )
UPD Benralizumab (Fasenra®) amended
17/12/2021 11:10:41
(LoweryM )
UPD sitematrix Changed from 0 to
17/12/2021 11:08:52
(LoweryM )
UPD BlueTeq Changed from N to Y
17/12/2021 11:08:52
(LoweryM )
UPD FurtherInformation Changed from

  • Approved for treating severe eosinophilic asthma in adults in line with NICE

to

 
17/12/2021 11:08:52
(LoweryM )
UPD Benralizumab (Fasenra®) blueteq badge added
17/12/2021 11:08:52
(LoweryM )
UPD Benralizumab Published from Draft Mode
30/05/2019 15:39:50
(DavidS )
LDL Link Added : NICE TA565: Benralizumab for treating severe eosinophilic asthma : https://www.nice.org.uk/guidance/ta565
25/04/2019 15:01:53
(DavidS )
UPD Benralizumab (Fasenra®) updated
25/04/2019 15:01:29
(DavidS )
UPD Benralizumab (Fasenra®) updated
25/04/2019 15:00:40
(DavidS )
ADD Benralizumab (Fasenra®) added NICE TA 565
25/04/2019 14:51:12
(DavidS )

 

 
netFormulary